KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 5,900.00
+200.00 (3.51%)
At close: Jan 28, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 117.87 billion as of January 29, 2026. Its market cap has increased by 11.64% in one year.
Market Cap
117.87B
Enterprise Value
99.68B
Revenue
71.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,900.00
Market Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 117.87B, a decrease of -76.10%. That is a compound annual growth rate of -24.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 117.87B | 5.93% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 151.50B |
| BIO-FD&C | 139.74B |
| TegoScience | 120.42B |
| Parataxis Korea | 117.75B |
| CTCBIO | 106.87B |
| Progen | 99.17B |
| IMGT Co.,Ltd. | 98.28B |
| Cell Biotech | 90.34B |